Back

Development and validation of a 2-year MACCE prediction model incorporating routine biomarkers in young patients with premature coronary heart disease: a multicenter study

30 August 2026 (09:15 - 09:40)
Organised by: Logo
Congress Presentation Part of: Predicting risk of future heart disease Biomarkers ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Jingjing Xu

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular D, Beijing (China)

1 More presentation in this session

Presentation thumbnail
Increased C-reactive protein–triglyceride glucose index is associated with the incidence of hypertension in individuals without hypertension: a large-scale retrospective cohort study
Miss Y. Su (Beijing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Predicting risk of future heart disease

The Event

Event poster

ESC Congress 2026

30 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Recurrence of cardiovascular events despite achieving LDL-C <1.4 mmol/L i in patients with coronary artery disease
29 August 2026
thumbnail
Congress Presentation
Clinical characteristics and long-term prognosis of patients with premature acute myocardial infarction
29 August 2025
thumbnail
Congress Presentation
A novel prediction model for heart failure-related death in hypertrophic cardiomyopathy
29 August 2026
thumbnail
Congress Presentation
Soluble transferrin receptor and hepcidin but not standard iron biomarkers are reliable prognostic biomarkers in heart failure
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources